| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.21 | 7e-05 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-05 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-05 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |